4.7 Article

Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16

期刊

INTERNATIONAL JOURNAL OF CANCER
卷 136, 期 6, 页码 E638-E645

出版社

WILEY
DOI: 10.1002/ijc.29196

关键词

human papillomavirus (HPV); HPV16; DNA methylation; cervical intraepithelial neoplasia (CIN); biomarker

类别

资金

  1. Canadian Institutes of Health Research [CRN-83320, MOP-42532]
  2. Cancer Research UK [C569/A10404]
  3. Reseau FRSQ SIDA-MI
  4. Sigrid Juselius Foundation Fellowship
  5. Finnish Medical Foundation
  6. Maud Kuistila Memorial Foundation
  7. Merck in Aid of Investigator-initiated Studies
  8. Merck Sharp and Dome
  9. Roche Diagnostics
  10. Merck
  11. Roche
  12. Abbott
  13. BD
  14. Hologic
  15. Qiagen
  16. Genera
  17. Trovagone
  18. Cancer Research UK [16891] Funding Source: researchfish

向作者/读者索取更多资源

Methylation of human papillomavirus (HPV) and host genes may predict cervical cancer risk. We examined the methylation status of selected sites in HPV16 and human genes in DNA extracted from exfoliated cervical cell samples of 244 women harboring HPV16-positive cancer or cervical intraepithelial neoplasia (CIN) or negative for intraepithelial lesions or malignancy (NILM). We quantified the methylation of CpG sites in the HPV16 L1 gene (CpG 6367 and 6389) and in the human genes EPB41L3 (CpG 438, 427, 425) and LMX1 (CpG 260, 262, 266, 274) following bisulfite treatment and pyrosequencing. Receiver operating characteristic (ROC) curves were used to analyze the diagnostic utility of methylation level for the different sites and for a joint predictor score. Methylation in all sites significantly increased with lesion severity (p<0.0001). Area under the curve (AUC) was highest among the CIN2/3 vs. cancer ranging from 0.786 to 0.853 among the different sites. Site-specific methylation levels strongly discriminated CIN2/3 from NILM/CIN1 and cancer from CIN2/3 (range of odds ratios [OR]: 3.69-12.76, range of lower 95% confidence bounds: 1.03-4.01). When methylation levels were mutually adjusted for each other EPB41L3 was the only independent predictor of CIN2/3 vs. NILM/CIN1 contrasts (OR=9.94, 95%CI: 2.46-40.27). High methylation levels of viral and host genes are common among precancerous and cancer lesions and can serve as independent risk biomarkers. Methylation of host genes LMX1 and EPB41L3 and of the viral HPV16 L1 sites has the potential to distinguish among precancerous lesions and to distinguish the latter from invasive disease. What's New? Cervical cancer detection in women with human papillomavirus (HPV) infection may be aided by the identification of methylation markers in host and viral DNA. In this analysis of methylation sites in human DNA and HPV16, methylation levels in both host and viral genes were found to increase with lesion severity. Methylation levels at sites in the human genes EPB41L3 and LMX1 and the HPV16 L1 gene distinguished cervical intraepithelial neoplasia (CIN) 2/3 from negative for intraepithelial lesions or malignancy (NILM)/CIN1 and cancer from CIN2/3. The methylation sites represent potential prognostic or diagnostic markers for cervical lesions in HPV-positive women.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据